News
The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...
Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...
Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.
In the fourth part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, explains the market dynamics or stakeholder misalignments that need to be resolved in order for the next ...
In the first multinational study of a proposed change to how obesity is defined—which calls for health factors beyond a ...
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
Novo Nordisk A/S (NYSE:NVO) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 18, Novo Nordisk A/S ...
GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results